tirzepatide shot schedule Injection At-Home Tirzepatide Weight Loss Injections in

If symptoms persist or worsen, contact your provider

Inflammatory mediators released during infection and surgical stress (e.g., IL-6, IL-10) can remodel hepatic and cutaneous immune microenvironments, thereby amplifying drug toxicity

however, there is a need for further research on this purpose before approval

Tirzepatide is administered as a once-weekly subcutaneous injection , typically starting at a low dose (2.5 mg) and gradually titrated upwards (to 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg) at approximately 4-week intervals to optimise efficacy whilst minimising gastrointestinal side effects

Nutrients (2018) 10(9):1203